| Date | Product | Disease | Phase | Company | Therapeutic area |
|---|---|---|---|---|---|
| 2014-02-05 | ABTL0812 (sodium 2-hydroxylinoleate) | advanced solid tumors | 1 | Ability Pharmaceuticals (Spain) | Cancer - Oncology |
| 2014-02-04 | ConfirmMDx® for Prostate Cancer | aggressive prostate cancer | MDxHealth (Belgium) | Cancer - Oncology | |
| 2014-02-04 | STP206 (Lactobacillus acidophilus and Bifidobacterium animalis subsp. Lactis) | prevention of necrotizing enterocolitis (NEC) in very low birth weight premature infants |
1-2 | Sigma-Tau Pharmaceuticals (USA – MD) | Rare diseases - Inflammatory diseases |
| 2014-02-03 | MGN1601 | renal cancer | 1-2 | Mologen (Germany) | Cancer - Oncology |
| 2014-02-01 | MEDI1814 | Alzheimer\'s disease | 1 | AstraZeneca | Neurodegenerative diseases |
| 2014-01-29 | gH1-Qbeta - H1N1 influenza vaccine candidate based on Cytos’ proprietary bacteriophage Qbeta virus-like particle (VLP) technology | H1N1 influenza infection | 1 | Agency for Science, Technology and Research (A*STAR) (Singapore) Cytos Biotechnology (Switzerland) | Infectious diseases |
| 2014-01-29 | GLPG0634 | Crohn\'s disease |
2 | Galapagos (Belgium) | Autoimmune diseases - Inflammatory diseases - Digestive diseases |
| 2014-01-29 | antibody treatment DI-B4 | B-cell lymphoma | Cancer Research UK (UK) | Cancer - Oncology | |
| 2014-01-28 | epidemic keratoconjunctivitis | 2 | Adenovir Pharma (Sweden) | Infectious diseases - Ophtalmological diseases | |
| 2014-01-28 | duvelisib and ofatumumab | chronic lymphocytic leukemia, small lymphocytic lymphoma | 3 | Infinity Pharmaceuticals (USA - MA) | Cancer - Oncology |
| 2014-01-21 | bitopertin | schizophrenia | 3 | Roche (Switzerland) | CNS diseases - Mental diseases |
| 2014-01-15 | ASP5878 | solid tumors | 1 | Astellas Pharma (Japan) | Cancer - Oncology |
| 2014-01-14 | avelumab (MSB0010718C) | solid tumors | 1 | Merck KGaA (Germany) | Cancer - Oncology |
| 2014-01-14 | DP-b99 | pancreatitis | 2 | D-Pharm (Israel) | Inflammatory diseases |
| 2014-01-14 | NIRsupreme™ ridaforolimus-eluting stent | coronary artery disease |
Medinol (Israel) Ariad Pharmaceuticals (USA - MA) | Cardiovascular diseases | |
| 2014-01-13 | Nefecon® (Nefigan - budesonide) | primary IgA nephropathy |
2b | Pharmalink (Sweden) | Renal diseases - Rare diseases - Kidney diseases |
| 2014-01-13 | simeprevir (TMC435), samatasvir (IDX719), TMC647055 | hepatitis C | 2 | Medivir (Sweden) Janssen Pharmaceuticals (J&J - USA) Idenix Pharmaceuticals (USA) | Infectious diseases |
| 2014-01-10 | 2B3-101 | glioma |
preclinical | to-BBB (The Netherlands) | Cancer - Oncology |
| 2014-01-09 | combination of ganetespib and paclitaxel | Synta Pharmaceuticals (USA) | Cancer - Oncology | ||
| 2014-01-09 | anti-pTau vaccine ACI-35 | Alzheimer’s disease |
1 | AC Immune (Switzerland) | Neurodegenerative diseases |
